BROGNARA, Eleonora
 Distribuzione geografica
Continente #
NA - Nord America 4.787
AS - Asia 2.890
EU - Europa 1.795
SA - Sud America 465
AF - Africa 62
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.004
Nazione #
US - Stati Uniti d'America 4.701
SG - Singapore 990
CN - Cina 919
PL - Polonia 382
BR - Brasile 379
IT - Italia 344
VN - Vietnam 271
UA - Ucraina 245
DE - Germania 242
HK - Hong Kong 222
GB - Regno Unito 160
TR - Turchia 159
SE - Svezia 98
FI - Finlandia 88
IN - India 73
FR - Francia 71
JP - Giappone 68
RU - Federazione Russa 63
MX - Messico 39
CA - Canada 35
BD - Bangladesh 34
ID - Indonesia 33
AR - Argentina 30
ZA - Sudafrica 23
NL - Olanda 19
ES - Italia 17
CO - Colombia 16
IR - Iran 16
IQ - Iraq 15
BE - Belgio 12
PK - Pakistan 12
LT - Lituania 11
CL - Cile 10
CZ - Repubblica Ceca 9
SA - Arabia Saudita 9
VE - Venezuela 9
EC - Ecuador 8
EG - Egitto 8
MY - Malesia 8
PH - Filippine 8
AT - Austria 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
BO - Bolivia 5
CH - Svizzera 5
DZ - Algeria 5
IE - Irlanda 5
JO - Giordania 5
KE - Kenya 5
KR - Corea 5
TN - Tunisia 5
TW - Taiwan 5
UZ - Uzbekistan 5
AU - Australia 4
AZ - Azerbaigian 4
LB - Libano 4
RO - Romania 4
IL - Israele 3
NP - Nepal 3
PE - Perù 3
RS - Serbia 3
UY - Uruguay 3
BB - Barbados 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
HU - Ungheria 2
JM - Giamaica 2
LK - Sri Lanka 2
PA - Panama 2
PY - Paraguay 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BT - Bhutan 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
PS - Palestinian Territory 1
PT - Portogallo 1
RE - Reunion 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
VC - Saint Vincent e Grenadine 1
Totale 10.004
Città #
Singapore 623
Ashburn 523
Woodbridge 470
Warsaw 379
Fairfield 372
Beijing 355
Jacksonville 293
Houston 289
San Jose 247
Chandler 243
Ann Arbor 229
Hong Kong 219
Santa Clara 219
Wilmington 170
Cambridge 125
Seattle 124
Nanjing 107
Izmir 89
Ho Chi Minh City 86
Ferrara 83
Hanoi 69
Tokyo 65
Los Angeles 64
New York 61
Princeton 61
Bologna 55
Boardman 53
Council Bluffs 50
Lauterbourg 50
Dallas 46
Munich 42
Bremen 33
Milan 32
Shanghai 32
San Diego 30
São Paulo 29
Nanchang 28
Shenyang 28
Mexico City 26
Orem 26
Falls Church 24
Helsinki 24
Jakarta 23
Dearborn 22
Addison 19
Changsha 19
Redwood City 19
Jiaxing 18
London 16
Tianjin 16
Hebei 15
Moscow 15
Rio de Janeiro 15
Guangzhou 14
Mountain View 14
Rome 14
Auburn Hills 12
Chennai 12
Da Nang 12
Frankfurt am Main 12
Montreal 12
Brussels 11
Jinan 11
Johannesburg 11
Toronto 11
Curitiba 10
Denver 10
The Dalles 10
Atlanta 9
Brooklyn 9
Chicago 9
Columbus 9
Dhaka 9
Manchester 9
Stockholm 9
Baghdad 8
Belo Horizonte 8
Des Moines 8
Dong Ket 8
Haiphong 8
Norwalk 8
Poplar 8
Quận Ba 8
Boston 7
Brasília 7
Buffalo 7
Chandigarh 7
Hangzhou 7
Kunming 7
Mumbai 7
San Francisco 7
Turku 7
Zhengzhou 7
Ankara 6
Campinas 6
Changchun 6
Hefei 6
New Delhi 6
Ningbo 6
Ninh Bình 6
Totale 6.785
Nome #
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Ew trends in the development of miRNA therapeutic strategies in oncology 330
Biological activity of anti-miR-221 Peptide Nucleic Acids and relative building blocks 315
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 242
Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells 237
Cellular Uptakes, Biostabilities and Anti-miR-210 Activities of Chiral Arginine-PNAs in Leukaemic K562 Cells 236
High levels of apoptosis are induced in human glioma cell lines by co-administration of peptide nucleic acids targeting miR-221 and miR-222 234
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 225
Corilagin Induces High Levels of Apoptosis in the Temozolomide-Resistant T98G Glioma Cell Line 221
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 220
Induction of apoptosis of human glioma cell lines: Effects of combined treatment with corilagin and temozolomide 217
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 211
In vitro evaluation of anti-proliferative and geno-protective activity of Hemidesmus indicus crude drug extracts 209
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 209
Corilagin is a potent inhibitor of NF-kappaB activity and downregulates TNF-alpha induced expression of IL-8 gene in cystic fibrosis IB3-1 cells 208
Regulation of IL-8 gene expression in gliomas by microRNAs 202
Regulation of IL-8 gene expression in gliomas by microRNA miR-93 192
Alteration of microRNA biological activity with peptide nucleic acid 185
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 185
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 182
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 178
Mithramycin encapsulated in polymeric micelles by microfluidic technology as novel therapeutic protocol for beta-thalassemia 174
miRNA therapeutics: delivery and biological activity of peptide nucleic acids targeting miRNAs 171
Development and molecular characterization of transgenic mice for beta-thalassemia 171
Inhibition of Cancer Cell Proliferation and Antiradical Effects of Decoction, Hydroalcoholic Extract, and Principal Constituents of Hemidesmus indicus R. Br 170
Corilagin is a potent inhibitor of NF-kappaB activity and expression of TNF-alpha induced IL-8 gene in cystic fibrosis IB3-1 cells 167
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 166
Encapsulation of mithramycin into polymeric micelles by microfluidics: Regulation of the expression of the human γ-globin genes 165
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts 164
PRODOTTI ERBORISTICI CONTENENTI TRANS-RESVERATROLO IN VENDITA ON-LINE: UN'INDAGINE SULLA QUALITA' 162
Gene therapy combined with HbF induction in beta-thalassemia 159
Targeting microRNAs involved in human diseases: A novel approach for modification of gene expression and drug development 154
Gene therapy and fetal hemoglobin induction 152
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 152
Targeting the miR-221/miR-222 cluster in cancer therapy 151
Trans-Resveratrol in nutraceuticals: issuses in retail quality and effectiveness 151
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 146
Peptide nucleic acids targeting miR-221 in human breast cancer: uptake and modulation of miR-221 biological functions. 146
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 146
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 141
Cytotoxic activity of C-geranyl compounds from Paulownia tomentosa fruits 138
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 135
Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives 133
Peptide nucleic acids targeting miR-221 in breast cancer cell lines: uptake and modulation of miR-221 and p27kip1 biological function 130
Inhibition of micro RNA 210 biological activity with an anti-miR-210 peptide nucleic acid 130
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 130
In vitro evaluation of the anti-proliferative and geno-protective activity of traditional preparations of ayurvedic crude drugs 129
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts. 128
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 128
Targeting pre-miRNA by Peptide Nucleic Acids: A new strategy to interfere in the miRNA maturation 127
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 124
Targeting miR‑155‑5p and miR‑221‑3p by peptide nucleic acids induces caspase‑3 activation and apoptosis in temozolomide‑resistant T98G glioma cells 124
Induction of high levels of apoptosis of temozolomide-resistant T98G glioma cells by co-administration of peptide nucleic acids targeting miR-221 and miR-222 116
Inhibition of micro RNA 221 biological activity with an anti-miR-221 peptide nucleic acid 109
Peptide nucleic acids targeting miR-221 in human gliomas: uptake and modulation of miR-221 biological functions 108
Readthrough of the premature stop codon beta039-thalassemia 106
Polyarginine peptide nucleic acids inhibit biological activity if microRNA 210 105
null 103
Molecular methods for validation of the biological activity of peptide nucleic acids targeting microRNAs. 95
null 92
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia 90
New Uracil Dimers Showing Erythroid Differentiation Inducing Activities 74
null 61
null 40
Totale 10.101
Categoria #
all - tutte 40.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 658
Totale 41.395


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021244 0 0 0 0 0 0 0 0 0 0 171 73
2021/2022612 54 66 28 20 47 32 21 22 24 54 72 172
2022/2023594 67 57 10 73 112 81 36 43 63 4 36 12
2023/2024365 36 26 13 13 48 51 31 17 12 4 29 85
2024/20251.254 31 37 104 60 140 125 60 52 183 164 158 140
2025/20263.319 342 153 261 498 500 213 339 217 394 387 15 0
Totale 10.101